Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Distinguishing EGFR mutation molecular subtypes based on MRI radiomics features of lung adenocarcinoma brain metastases.

Clinical neurology and neurosurgery - 1 May 2024

Xu Jiali, Yang Yuqiong, Gao Zhizhen, Song Tao, Ma Yichuan, Yu Xiaojun, Shi Changzheng

Abstract excerpt

OBJECTIVE: To explore the feasibility of identifying epidermal growth factor receptor (EGFR) mutation molecular subtypes in primary lesions based on the radiomics features of lung adenocarcinoma brain metastases using magnetic resonance imaging (MRI). METHODS: We retrospectively analyzed clinical, imaging, and genetic testing data of patients with lung adenocarcinoma with EGFR gene mutations who had brain...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma of Lung
Share to Aged

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Brain Neoplasms

Share to ErbB Receptors

Share to Lung Neoplasms

Share to Magnetic Resonance Imaging

Share to Mutation

Share to Radiomics

Source

Identifiers

PMID: 38552362
DOI: 10.1016/j.clineuro.2024.108258

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Distinguishing EGFR mutation molecular subtypes based on MRI radiomics features of lung adenocarcinoma brain metastases.PMID 38552362Read ↗

MRI-Based Radiomics Nomogram as a Potential Biomarker to Predict the EGFR Mutations in Exon 19 and 21 Based on Thoracic Spinal Metastases in Lung Adenocarcinoma.Semantic proximity Read ↗

Radiomics signature of brain metastasis: prediction of EGFR mutation status.Semantic proximity Read ↗

Development and validation of MRI-based radiomics signatures as new markers for preoperative assessment of EGFR mutation and subtypes from bone metastases.Semantic proximity Read ↗

Radiomic prediction of mutation status based on MR imaging of lung cancer brain metastases.Semantic proximity Read ↗

Radiomics predicts the EGFR mutation and subtypes in metastatic lung adenocarcinoma: a multi-center studySemantic proximity Read ↗

Contrast-enhanced MRI-based radiomics signatures as new markers for preoperative assessment of the EGFR mutation and subtypes from bone metastasesSemantic proximity Read ↗

3D radiomics predicts EGFR mutation, exon-19 deletion and exon-21 L858R mutation in lung adenocarcinomaSemantic proximity Read ↗

Radiomic signatures for the non-invasive prediction of EGFR mutation status in brain metastases of lung adenocarcinomaSemantic proximity Read ↗

Multiparametric MRI-Based Radiomics Approaches for Preoperative Prediction of EGFR Mutation Status in Spinal Bone Metastases in Patients with Lung Adenocarcinoma.Semantic proximity Read ↗

Contrast-enhanced T1-weighted image radiomics of brain metastases may predict EGFR mutation status in primary lung cancer.Semantic proximity Read ↗

A deep learning model integrating multisequence MRI to predict EGFR mutation subtype in brain metastases from non-small cell lung cancer.Semantic proximity Read ↗

Deep learning radiomics for the prediction of epidermal growth factor receptor mutation status based on MRI in brain metastasis from lung adenocarcinoma patientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.